Thomas Michael P, Jung Park Yeo, Grey Scott, Schreiber Theodore L, Gurm Hitinder S, Leffler Dale, Davis Thomas P, Henke Peter, Michael Grossman Paul
Division of Cardiovascular Medicine, Interventional Cardiology, University of Michigan, Ann Arbor, Michigan.
Division of Cardiovascular Medicine, Interventional Cardiology, VA Ann Arbor Healthcare System, Ann Arbor, Michigan.
Catheter Cardiovasc Interv. 2017 Mar 1;89(4):728-734. doi: 10.1002/ccd.26883. Epub 2017 Feb 27.
The aim is to examine trends in procedural indication, arterial beds treated, and device usage in peripheral arterial interventions (PVIs).
There is little data on indication, vascular beds treated and devices utilized for peripheral arterial interventions.
We used data from 43 hospitals participating in the BMC2 VIC registry. PVIs were separated by year and divided by arterial segment. Lower extremity PVIs were subclassified as having been performed for claudication or critical limb ischemia (CLI). Yearly device usage was also included. A repeated measure ANOVA was used to determine trends.
44,650 PVIs were performed from 2006 to 2013. Renal interventions decreased from 18% of interventions in 2006 to 5.6% in 2013 (P < 0.001) and femoral-popliteal increased from 54.9% in 2006 to 64.5% in 2013 (P < 0.001). No significant trend was seen for aorta-iliac or below-the-knee interventions. 58.6% of PVIs were performed for claudication in 2006 and this decreased to 44.6% in 2013 (P = 0.025). Indications for CLI were 24.1% in 2006 and 47.5% in 2013 (P < 0.001). There were significant increases in the use of balloon angioplasty (P = 0.029) and cutting/scoring balloons (P < 0.001) while cryoballoon usage decreased (P < 0.001). No significant changes were found with stenting, atherectomy, and laser.
There is a significant increase in patients presenting with CLI. Renal artery intervention rates are decreasing while femoral-popliteal interventions are increasing. Additionally, balloon angioplasty and cutting/scoring balloon usage is increasing. © 2017 Wiley Periodicals, Inc.
旨在研究外周动脉介入治疗(PVI)中手术指征、治疗的动脉床以及器械使用情况的趋势。
关于外周动脉介入治疗的指征、治疗的血管床以及所使用的器械的数据很少。
我们使用了参与BMC2 VIC注册研究的43家医院的数据。PVI按年份进行分类,并按动脉节段进行划分。下肢PVI又进一步细分为因间歇性跛行或严重肢体缺血(CLI)而进行的手术。还纳入了每年的器械使用情况。采用重复测量方差分析来确定趋势。
2006年至2013年共进行了44,650例PVI。肾动脉介入治疗从2006年占介入治疗的18%降至2013年的5.6%(P < 0.001),股腘动脉介入治疗从2006年的54.9%增至2013年的64.5%(P < 0.001)。腹主动脉 - 髂动脉或膝下介入治疗未观察到明显趋势。2006年58.6%的PVI是因间歇性跛行而进行的,到2013年这一比例降至44.6%(P = 0.025)。CLI的指征在2006年为24.1%,在2013年为47.5%(P < 0.001)。球囊血管成形术(P = 0.029)和切割/刻痕球囊的使用显著增加(P < 0.001),而冷冻球囊的使用减少(P < 0.001)。支架置入术、旋切术和激光治疗未发现显著变化。
CLI患者数量显著增加。肾动脉介入治疗率下降,而股腘动脉介入治疗率上升。此外,球囊血管成形术和切割/刻痕球囊的使用正在增加。© 2017威利期刊公司